cardiotonic agents

Preferred Label : cardiotonic agents;

MeSH definition : Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).;

MeSH synonym : myocardial stimulants; inotropic agents, positive cardiac; cardiotonics; cardiac stimulants; cardiotonic drugs; cardioprotective agents; Cardiotonic; Myocardial Stimulant; Stimulant, Myocardial; Cardioprotective Agent; Agent, Cardioprotective; Cardiotonic Agent; Agent, Cardiotonic; Cardiac Stimulant; Stimulant, Cardiac; Cardiotonic Drug; Drug, Cardiotonic;

MeSH annotation : do not confuse with CARDIOTOXINS;

Wikipedia link : https://en.wikipedia.org/wiki/Cardiac stimulant;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D002316;

UMLS CUI

C0007209;

ATC code(s)
- cymarin [ATC Code]
- metildigoxin [ATC Code]
- oxyfedrine, combinations [ATC Code]
- peruvoside [ATC Code]
ATC code(s)
- acetyldigitoxin [ATC Code]
- acetyldigoxin, combinations [ATC Code]
- amrinone [ATC Code]
- arbutamine [ATC Code]
- cardiac stimulants excl. cardiac glycosides [ATC Code]
- deslanoside [ATC Code]
- digitalis glycosides [ATC Code]
- digitoxin [ATC Code]
- digoxin [ATC Code]
- dobutamine [ATC Code]
- dopamine [ATC Code]
- enoximone [ATC Code]
- fosfocreatine [ATC Code]
- g-strophanthin [ATC Code]
- ibopamine [ATC Code]
- isoprenaline [ATC Code]
- levosimendan [ATC Code]
- metaraminol [ATC Code]
- milrinone [ATC Code]
- norfenefrine [ATC Code]
- other cardiac glycosides [ATC Code]
- other cardiac stimulants [ATC Code]
- oxedrine [ATC Code]
- phenylephrine [ATC Code]
- phosphodiesterase inhibitors [ATC Code]
- prenalterol [ATC Code]
- proscillaridin, combinations [ATC Code]
- scilla glycosides [ATC Code]
- strophantus glycosides [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Artificial cardiac pacemaker [LOINC System]
- CARDIAC PACEMAKER [Cladimed Sub-Gamm]
- Cardiac pacemaker prosthetic [LOINC component]
- Cardiac pacemaker, device (physical object) [SNOMED CT concept]
- Cardiotonic Agent [NCIt concept]
- Cardiotonic agent (substance) [Inactive SNOMED CT concept]
- cardiac pacemaker [SNOMED Notion]
- cardiotonic drug, nos [SNOMED Notion]
False automatic mappings
- Cisplatin/Methotrexate Regimen [NCIt concept]
Indexing information
- 1-(2-oxo-2-phenylacetyl)-N-(3-phenylpropyl)piperidine-2-carboxamide [MeSH Supplementary Concept]
- 10-O-dimethylaminoethylginkgolide B [MeSH Supplementary Concept]
- 3,5-dimethoxy-4-(3-(2-carbonyl-ethyldisulfanyl)-propionyl)benzoic acid 4-guanidinobutyl ester [MeSH Supplementary Concept]
- 3-(4-bromo-phenoxy)-4,5-dihydroxybenzoic acid-methyl ester [MeSH Supplementary Concept]
- 3-(6-(4-oxo-4H-1,3-benzothiazin-2-yl)pyridin-2-yl)propanoic acid [MeSH Supplementary Concept]
- 5-((3,4-methylenedioxyphenylethane)methylamino)-1-p-hydroxyphenyl-1-penten-3-one [MeSH Supplementary Concept]
- Ac-ANX-A1(2-26) peptide [MeSH Supplementary Concept]
- N-(2,2,2-trichloro-1-(4-(4-chlorophenyl)thiazol-2-ylamino)ethyl)cinnamamide [MeSH Supplementary Concept]
- N-(4-cyanophenyl)-N'-cyano-N''-(3,4-dihydro-3-hydroxy-6-((N,N-diisobutylamino)sulfonyl)-2,2-dimethyl-2H-1-benzopyran-4-yl)guanidine [MeSH Supplementary Concept]
- RC 552 [MeSH Supplementary Concept]
- T89 herbal drug [MeSH Supplementary Concept]
- chrysoeriol 7-O-(glucuronopyranosyl-(1-2)-O-glucuronopyranoside) [MeSH Supplementary Concept]
- ginkgo biloba extract 50 [MeSH Supplementary Concept]
- podocarflavone A [MeSH Supplementary Concept]
- rutecarpine [MeSH Supplementary Concept]
- yi-qi-fu-mai [MeSH Supplementary Concept]
Record concept(s)
- cardiotonic agents [MeSH concept]
See also
- heart [MeSH Descriptor]
- myocardial contraction [MeSH Descriptor]
- sympathomimetics [MeSH Descriptor]
See also inter- (CISMeF)
- cardioprotectant agent [Disease (Nov.)]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one [MeSH Supplementary Concept]
- 4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone [MeSH Supplementary Concept]
- 5-(4-acetamidophenyl)pyrazin-2(1H)-one [MeSH Supplementary Concept]
- 6-hydroxymelatonin [MeSH Supplementary Concept]
- BDF 9148 [MeSH Supplementary Concept]
- BMS 180448 [MeSH Supplementary Concept]
- DPI 201-106 [MeSH Supplementary Concept]
- EMD 53998 [MeSH Supplementary Concept]
- ICI D2788 [MeSH Supplementary Concept]
- MCI 154 [MeSH Supplementary Concept]
- Simendan [MeSH Descriptor]
- UD CG 212 cl [MeSH Supplementary Concept]
- acetyldigitoxins [MeSH Descriptor]
- acetyldigoxins [MeSH Descriptor]
- acrihellin [MeSH Supplementary Concept]
- adrenomedullin [MeSH Descriptor]
- alifedrine [MeSH Supplementary Concept]
- aminophylline [MeSH Descriptor]
- amrinone [MeSH Descriptor]
- anthopleurin-A [MeSH Supplementary Concept]
- arbutamine [MeSH Supplementary Concept]
- bimakalim [MeSH Supplementary Concept]
- bufalin [MeSH Supplementary Concept]
- bufanolides [MeSH Descriptor]
- bufogenin [MeSH Supplementary Concept]
- canertinib dihydrochloride [MeSH Supplementary Concept]
- cannogenin thevetoside [MeSH Supplementary Concept]
- carbachol [MeSH Descriptor]
- cardiac glycosides [MeSH Descriptor]
- colforsin [MeSH Descriptor]
- cymarine [MeSH Descriptor]
- denopamine [MeSH Supplementary Concept]
- deslanoside [MeSH Descriptor]
- dexrazoxane [MeSH Descriptor]
- digitalis glycosides [MeSH Descriptor]
- digitoxin [MeSH Descriptor]
- digoxin [MeSH Descriptor]
- dobutamine [MeSH Descriptor]
- dopamine [MeSH Descriptor]
- draflazine [MeSH Supplementary Concept]
- enoximone [MeSH Descriptor]
- etilefrine [MeSH Descriptor]
- gidazepam [MeSH Supplementary Concept]
- helenalin [MeSH Supplementary Concept]
- higenamine [MeSH Supplementary Concept]
- ibopamine [MeSH Supplementary Concept]
- imazodan [MeSH Supplementary Concept]
- isoproterenol [MeSH Descriptor]
- lisinopril [MeSH Descriptor]
- medigoxin [MeSH Descriptor]
- milrinone [MeSH Descriptor]
- olprinone [MeSH Supplementary Concept]
- ouabain [MeSH Descriptor]
- oxyfedrine [MeSH Descriptor]
- phenylephrine [MeSH Descriptor]
- phosphocreatine [MeSH Descriptor]
- pimobendan [MeSH Supplementary Concept]
- pirbuterol [MeSH Supplementary Concept]
- piroximone [MeSH Supplementary Concept]
- plumbagin [MeSH Supplementary Concept]
- potassium magnesium aspartate [MeSH Descriptor]
- prenalterol [MeSH Descriptor]
- propionylcarnitine [MeSH Supplementary Concept]
- proscillaridin [MeSH Descriptor]
- sanguinarine [MeSH Supplementary Concept]
- strophanthin K [MeSH Supplementary Concept]
- strophanthins [MeSH Descriptor]
- sulmazole [MeSH Supplementary Concept]
- tedisamil [MeSH Supplementary Concept]
- toborinone [MeSH Supplementary Concept]
- toxin II (Anemonia sulcata) [MeSH Supplementary Concept]
- vesnarinone [MeSH Supplementary Concept]
- zatebradine [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients